| Factor Information | |
|---|---|
| Data ID | 708 |
| Factor | NT-proBNP |
| Description | N/A |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | APAH-CHD |
| p Value | <0.001 |
| Conclusion | In the PAH after defect correction group, patients were much more likely to have higher plasma level of NT-proBNP. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 477 |
| CHD Type | isolated CHD |
| CHD Subtype | CHD with PAH/EA |
| Reference | |
|---|---|
| PMID | 28966315 |
| Year | 2017 |
| Title | Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | China, Beijing | |
| Method | T-test and analysis of variance | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac operation | |
| Group | PAH after defect correction(Treatment) | Eisenmenger syndrome; PAH with small defects(Control) |
| Number | 43 | 112(Eisenmenger syndrome), 20(PAH with small defects) |
| Age | 26±9 years | 29±9 years(Eisenmenger syndrome), 32±11 years(PAH with small defects) |
| Gender (Male: Female) | 9:34 | 33:79(Eisenmenger syndrome), '4:16(PAH with small defects) |
| Marker Level | 1530.4±1014.3pg/mL | 808.7±612.1pg/mL(Eisenmenger syndrome), 1058.3±542.2pg/mL(PAH with small defects) |
